Hasta gruplarından(Grup I ile Grup II) kaybedilmiş olan hastaların tedavi öncesi serum NT-proBNP düzeyleri ile şifayla taburcu edilmiş olan hastaların teda

öncesi serum NT-proBNP düzeyleri arasında anlamlı bir ilişki tespit edilmedi (p=0,198).

1. Özkan N: Beyin Ödemi, Temel Nöroşirurji Cilt 2, Türk Nöröşirurji Derneği Yayınları, S: 924-29, 2005 Ankara.

2. Artrra AA: CSF Dynamics, Cerebral Edema, and intrracranial pressure, Ablin MS (ED), Textbook of Neuroanesthesia Mc Graw Hill Companies 1997, 61-115.

3. Koo AH, La Roque RL. Evaluation of head trauma by computed tomography. Radiology 1977; 123:345-60.

4. Pollary M: Blood Brain Barrier; Cerebral Edema. Wilkins RH, Rengachary SS (ED) Neurosurgery 1 Second ed. New York: Mc Grawvn Hill 1996, 335-44.

5. Miller JD: Traumatic brain swelling and edema. In Cooper PR (ed): Head injury. Baltimore, Williams and Wilkins 1993; p. 331-353-59.

6. Paşaoğlu, A. Erişkinde Kafa Travmaları. Temel Nöroşirurji Cilt I, Türk Nöroşirurji Derneği Yayınları, S.316-23: 2005 Ankara

7. Marmara Üniversitesi Tıp Fakültesi Pediatrik Acil Hastaya Yaklaşım Klavuzu 96-97-98 syf

8. Kinoshita K, Sakurai A, Utagawa A, Ebihara T, Furukawa M, Moriya T, et al. Importance of cerebral perfusion pressure management using cerebrospinal drainage in severe traumatic brain injury. Acta Neurochir Suppl 2006;96:37-39.

9. Alp H: Beyin Ödemi. Temel Norosururji 1. Ankara 1997; p. 1-15. 10. Castillo LR, Robertson CS. Management of intracranial hypertension. Crit Care Clin 2007;22:713-32.

11. Greenberg MS. Handbook of Neurosurgery. 6th _{ed. New York: Thieme} Medical Publishers, 2006

12. Dennis LJ, Mayer SA. Diagnosis and management of increased intracranial pressure. Neurol India 2001;49(Suppl 1):37-50.

13. Orban JC, Ichai C. Hierarchical strategy for treating elevated intracranial pressure in severe traumatic brain injury. Ann Fr Anesth Reanim 2007;26:440-44.

14. Kayaalp O: Rasyonel Tedavi Yönünden Tıbbi Farmakoloji: Hacettepe Taş Yayınları, S: 553-54, 2005

15. Kaufman AM, Cardosa ER: Aggrevation of vasogenic edema by multiple dose mannitol. J Neurosurgery 1992; 77: 584-89.

16. Adnan I, Quresh MD, Jose I. Use of hypertonic saline / asetate infussion in treatment of cerebral edema in patient with trauma: Experience at a single center. J Trauma. 1999:47:659-65.

17. Khanna S, Davis B, Peterson B. Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension traumatic brain injury. Crit Care Med. 2000;28:1114-15.

18. Doyle JA, J Travma 2001;50:367-389.

19. Zaloga GP, Kirby RR, Bernards W, Civetta JM. Fluids and Electroliytes. Critical Care. Thr. Ed. Lippincott Raven Publishers. 1997;437-440.

20. Saul TG, Ducker TB, Salcman M, Carro E. Steroids in severe head injury: a prospective, randomized clinical trial. J Neurosurg 1981;54:596-600.

21. Mark S, Greenberg, M.D. Bozbuğa Mustafa, Nöroşirurji ElKitabı, Nobel Tip Kitabevleri 1996

22. Tülek N, Tanyel E. Santral Sinir Sistemi Enfeksiyonlarına Genel Bakış. Topçu WA, Söyletir G, Doğanay M. (editörler). Enfeksiyon Hastalıkları ve Mikrobiyolojisi, İstanbul, Nobel Tıp Kitapevleri, 2008: 1375-90.

23. Prober CG. Central nervous system infections. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF (eds). Nelson textbook of pediatrics. 18th edition, Philadelphia: Saunders Elsevier; 2007; p. 2512-24.

24. Özdal GZ.2000-2005 Yılları arasında Kliniğimize Başvuran Meningokoksik Hastalıklı Olguların Değerlendirilmesi. 2006, Dicle Üniversitesi Tıp Fakültesi Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Uzmanlık Tezi, 69 sayfa, Diyarbakır, (Prof. Dr. M. Ali TAŞ)

25. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med. 1997 Oct 2;337(14):970 -76.

26. Nigrovic LE, Kuppermann N, Malley R. Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era. Acad Emerg Med. 2008 Jun;15(6):522-28.

27. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis. 1990 Dec;162(6):1316- 23.

28. Nigrovic LE, Malley R, Kuppermann N. Cerebrospinal fluid pleocytosis in children in the era of bacterial conjugate vaccines: distinguishing the child with bacterial and aseptic meningitis. Pediatric emergency care. 2009 Feb;25(2):112-7; quiz 8-20.

29. Saez-Liorens X, McCracken GH. Acute bacterial meningitis beyond the neonatal period. In: Long SS, Pickering LK, Prober CG (eds). Principles and practice of pediatric infectious diseases. 3th edition, Churchill Livingstone Elsevier; 2008; p. 284-91.

30. Dawson KG, Emerson JC, Burns JL. Fifteen years of experience with bacterial meningitis. Pediatr Infect Dis J 1999; 18: 816-22

31. Chavez-Bueno S, McCracken GH, Jr. Bacterial meningitis in children. Pediatric clinics of North America. 2005 Jun;52(3):795-810.

32. Stephens DS, Farley MM. Pathogenic events during infection of the human nasopharynx with Neisseria meningitidis and Haemophilus influenzae. Rev Infect Dis. 1991 Jan-Feb;13(1):22-33.

33. Kim KS. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nature reviews. 2003 May;4(5):376-85.

34. Joiner KA. Complement evasion by bacteria and parasites. Annu Rev Microbiol. 1988;42:201-30.

35. Brown EJ, Joiner KA, Gaither TA, Hammer CH, Frank MM. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system. J Immunol. 1983 Jul;131(1):409-15.

36. Simberkoff MS, Moldover NH, Rahal J, Jr. Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. A regional host defense deficiency. The Journal of laboratory and clinical medicine. 1980 Mar;95(3):362-72.

37. Tuomanen E, Tomasz A, Hengstler B, Zak O. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis. 1985 Mar;151(3):535-40.

38. Braun JS, Novak R, Herzog KH, Bodner SM, Cleveland JL, Tuomanen EI. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nature medicine. 1999 Mar;5(3):298-302.

39. Klein JO, Feigin RD, McCracken GH, Jr. Report of the Task Force on Diagnosis and Management of Meningitis. Pediatrics. 1986 Nov;78(5 Pt 2):959-82.

40. Feigin RD, McCracken GH, Jr., Klein JO. Diagnosis and management of meningitis. Pediatr Infect Dis J. 1992 Sep;11(9):785-814.

41. Van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004 Oct 28;351(18):1849-59.

42. Oostenbrink R, Moons KG, Theunissen CC, Derksen-Lubsen G, Grobbee DE, Moll HA. Signs of meningeal irritation at the emergency department: how often bacterial meningitis? Pediatr Emerg Care 2001; 17: 161-64.

43. Mace SE. Acute bacterial meningitis. Emerg Med Clin North Am 2008; 26: 281-317.

44. Parlak M. Akut Bakteriyel Menenjitler. Toplumda Edinilmiş Enfeksiyonlara Pratik Yaklaşımlar. İ.U.Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri. Sempozyum Dizisi No:61, 2008: 151-64.

45. Çocuk Enf Derg 2009; 3 (Özel Sayı 1): 43-7 J Pediatr Inf 2009; 3 (Suppl 1): 43-47.

46. Talan DA, Hoffman JR, Yoshikawa TT, Overturf GD. Role of empiric parenteral antibiotics prior to lumbar puncture in suspected bacterial meningitis: state of the art. Rev Infect Dis. 1988 Mar-Apr;10(2):365-76.

47. Feigin RD PE, ed. Bacterial meningitis beyond the neonatal period Saunders 2004

48. Arditi M, Mason EO, Jr., Bradley JS, Tan TQ, Barson WJ, Schutze GE, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998 Nov;102(5):1087-97.

49. Andersen J, Backer V, Voldsgaard P, Skinhoj P, Wandall JH. Acute meningococcal meningitis: analysis of features of the disease according to the age of 255 patients. Copenhagen Meningitis Study Group. The Journal of infection. 1997 May;34(3):227-35.

50. Gray LD, Fedorko DP. Laboratory diagnosis of bacterial meningitis. Clinical microbiology reviews. 1992 Apr;5(2):130-45.

51. Lu HC, Chang NM, Chuang YC.The prognostic factors of adult Gram negative bacillary meningitis. J Hosp Infect 1998; 40: 27-34.

52. Tzanakaki G, Mastrantonio P. Aetiology of bacterial meningitis and resistance to antibiotics of causative pathogens in Europe and in the Mediterranean region. Int J Antimicrob Agents 2007; 29: 621-29.

53. Yalçın I, Gürler N, Alhan E, et al. Serotype distrubition and antibiotic susceptibility of invasive S. pneumoniae disease isolates from children in Turkey, 2001-2004. Eur J Pediatr 2006; 165: 654-57.

54. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39: 1267-84.

55. Kaul A, Chandwani S. Dexamethasone in bacterial meningitis: to use or not to use? Indian J Pediatr 1996; 63: 583-89.

56. Chavez-Bueno S, McCracken GH. Bacterial meningitis in children. Pediatr Clin North Am 2005; 52: 795-10.

57. David R. Chadwick,Viral Meningitis .British Medical Bulletin 2005; 75 and 76:1-14.

58. David W. Kimberlin Herpes Simplex Virus Infections of the Central Nervous System, Seminars in Pediatric Infectious Diseases, 2003; 14(2): 83-89.

59. Koskiniemi M, Korppi M, Mustonen K et al. Epidemiology of encephalitis in children. A prospective multicenter study. Eur J Pediatr 1997;156:541-45.

60. Kolskı H, Ford-Jones EL, Rıchardson S, et al. Etıology of acute chıldhood encephalıtıs at the hospıtal for sıck chıldren, Toronto, 1994-1995. Clın Infect Dıs 1998; 26: 398-09.

61. Lahat E, Barr J, Barkaı G, Paret G, Brand N, Barzılaı A. Long term neurologıcal outcome of herpes encephalıtıs. Arch Dıs Chıld 1999; 80: 69-71.

62. Huang CC, Lıu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologıc complıcatıons ın chıldren wıth enterovırus 71 ınfectıon. N Engl J Med 1999; 341: 936-42.

63. Wılloughby RE, Long SS. Encephalıtıs, menıngoencephalıtıs, acute dıssemınated encephalomyelıtıs, and acute necrotızıng encephalopathy. In: Long SS, Pıckerıng LK, Prober CG (eds). Prıncıples and Practıce of Pedıatrıc Infectıous Dıseases. 3th edıtıon. Phıladelphıa: Churchıll Lıvıngstone Elsevıer; 2008. p. 310-18.

64. Xu Y, Zhaorı G, Vene S, et al. Vıral etıology of acute chıldhood encephalıtıs ın Beıjıng dıagnosed by analysıs of sıngle samples. Pedıatr Infect Dıs J 1996; 15: 1018-24.

65. Olcay neyzi / Türkân Ertuğrul Prof. Dr. Işık yalçın 1. cilt 2010; 4: 575-76

66. İ.Ü. Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri Akılcı Antibiyotik Kullanımı ve Erişkinde Toplumdan Edinilmiş Enfeksiyonla Sempozyum Dizisi No: 31 • Kasımm 2002; s. 141-51.

67. Clerico A, Emdin M. Natriuretic peptites the hormones of the heart. 1nd ed Springer, Italy 2006

68. Sudoch T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptite in porcine brain. Nature 1988;332:78–81.

69. Saper CB, Hurley KM, Moga MM, ve ark. Brain natriuretic peptites: Differential localization of a new family of neuropeptites. Neurosci Lett 1989; 96:29-34.

70. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003; 24:341-56.

71. Levin ER, Gardner DG, Samson WK. Natriuretic peptites. N Engl J Med 1998; 339:321-28.

72. Mair J, Friedl W, Thomas S, Puschendorf B. Natriuretic peptites inassessment of left-ventricular dysfunction. Scand J Clin Lab Invest Suppl 1999;230:132-42.

73. Davis GK, Bamforth F, Sarpal A, et al. B-type natriuretic peptite in pediatrics. Clin Biochem 2006;39:600-05.

74. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003; 24:341-56.

75. Nir A, Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology. J Card Fail 2005 ;11:76-80.

76. Baxter GF. The natriuretic peptites. Basic Res Cardiol 2004;99:71-75. 77. Leowattana W, Sirithunyanont C, Sukumalchantra Y, et al. Serum Nterminal pro-brain natriuretic peptite in normal Thai subjects. J Med Assoc Thai 2003;86: 46-51

78. Melzi d'Eril G, Tagnochetti T, Nauti A, et al. Biological variation of Nterminal pro-brain natriuretic peptite in healthy individuals. Clin Chem 2003; 49:1554-55

79. Mir TS, Laux R, Hellwege HH, et al. Plasma concentrations of aminoterminal pro atrial natriuretic peptite and aminoterminal pro brain natriuretic peptite in healthy neonates: marked and rapid increase after birth. Pediatrics. 2003;112:896-99

80. Rademaker MT, Richards AM. Cardiac natriuretic peptites for cardiac health. Clin Sci 2005;108:23-36.

81. Lainchbury JG, Burnett JC Jr, Meyer D, Redfield MM. Effects of natriuretic peptites on load and myocardial function in normal and heart failure dogs. Am J Physiol Heart Circ Physiol 2000;278:33-40

82. Koch A, Singer H. Normal values of B type natriuretic peptite in infants, children, and adolescents. Heart 2003;89:875-78.

83. Raymond I, Groenning BA, Hilderant PR, et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptite in a large sample of the general population. Heart 2003; 89: 745-51.

84. Mukoyama M, Nakao K, Obata K, et al. Augmented secretion of brain natriuretic peptite in acute myocardial infarction. Biochem Biophys Res Commun 1991;180:431-36.

85. Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis 2002; 44:293-321.

86. Davidson NC, Naas AA, Hanson JK, Kennedy NS, Coutie WJ, Struthers AD. Comparison of atrial natriuretic peptite B-type natriuretic peptite, and

N-terminal proatrial natriuretic peptite as indicators of left ventricular systolic dysfunction. Am J Cardiol. 1996; 77:828 –31.

87. Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptites and their receptors. Circulation. 1992; 86:1081–8

88. Lynch JR, Blessing R, White WD, Grocott HP, Newman MF, Laskowitz DT. Novel diagnostic test for acute stroke. Stroke 2004; 35:57–63.

89. Iltumur K, Karabulut A, Apak I, Aluclu U, Ariturk Z, Toprak N. Elevated plasma N - terminal pro-brain natriuretic peptite levels inacute ischemic stroke. Am Heart J 2006;151:1115–22.

90. Nakagawa K, Yamaguchi T, SeidaM, Yamada S, Imae S, Tanaka Y, et al. Plasma concentrations of brain natriuretic peptite in pati ents with acute ischemic stroke. Cerebrovasc Dis 2005; 19:157–64.

91. Makikallio AM, Makikallio TH, Korpelainen JT, Vuolteenaho O, Tapanainen JM, Ylitalo K, et al. Natriuretic peptites and mortality after stroke. Stroke 2005; 36:1016 –20.

92. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T. Atrium as a source of brain natriuretic polypeptite in patients with atrial fibrillation. J Card Fail 2000; 6:92–6.

93. Oppenheimer SM, Lima J. Neurology and the heart. J Neurol Neurosurg Psychiatry 1998; 64: 289-297.

94. McLean AS, Huang SJ, Nalos M, ve ark. The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptite concentrations in critically ill patients. Crit Care Med 2003; 31: 2611—2618.

95. McLean AS, Tang B, Nalos M, ve ark. Increased B-type natriuretic peptite (BNP) level is a strong predictor for cardiac dysfunction in the intensive care unit patients. Anaesth Intensive Care 2003; 31:21-27

96. Loke I, Squire IB, Davies JE, Ng LL. Reference ranges for natriuretic peptites for diagnostic use are depending on age, gender and heart rate. Eur J Heart Fail 2003; 5:599-606.

97. Troughton RW, Frampton CM, Yandle TG ve ark. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptite (N-BNP) concentrations. Lancet 2000; 355:1126—1130.

98. Akiba T, Tachibana K, Togashi K ve ark. Plasma human brain natriuretic peptite in chronic renal failure. Clin Nephrol 1995; 44:S61-S64.

99. Wahl HG, Graf S, Renz H, Fassbinder W. Elimination of the cardiac natriuretic peptites B-type natriuretic peptite (BNP) and N-Terminal ProBNP by hemodialysis. Clin Chem 2004; 50:1071-1074.

100. McLean AS, Poh G, Huang SJ. The effects of acute fluid loading on plasma B-type natriuretic peptite levels in a septic shock patient. Anaesth Intensive Care 2005; 33:528-530.

101. Byeon JH, Yoo G. Cerebral salt wasting syndrome after calvarial remodeling in craniosynostosis. J Korean Med Sci. 2005; 20:866-869.

102. Berger TM, Kistler W, Berendes E, Raufhake C, Walter M. Hyponatremia in a pediatric stroke patient: syndrome of inappropriate antidiuretic hormone secretion or cerebral salt wasting? Crit Care Med. 2002; 30:792-795.

103. Schwachtgen L, Herrmann M, Georg T ve ark. (2005) Reference values of NT-ProBNP serum concentrations in the umbilical cord blood and in healthy neonates and children. Z Kardiol 94: 399–404.

104. G. E. Sviri, J. F. Soustiel, and M. Zaaroor Alteration in brain natriuretic peptite (BNP) plasma concentration following severe traumatic brain injury. Acta Neurochir (Wien) (2006) 148: 529–33.

105. Schulz H, Langvik TA, Sagen EL, Smith J et al. Radioimmunassay for Nterminal pro brain natriuretic peptite in human plasma. Scand J Clin Invest 2001; 61: 33-42.

106. Cowley CG, Bradley JD, Shaddy RE. B-type natriuretic peptite levels in congenital heart disease. Pediatr Cardiol 2004; 25:336-40.

107. Mir TS, Marohn S, Eiselt M, Grollmus O, Weil J. Plasma concentrations of Nterminal pro-brain natriuretic peptite in control children from the neonatal to 74 adolescent period and in children with congestive heart failure. Pediatrics 2002; 110:76.

108. Nir A, Bar-Oz B, Perles Z, Brooks R, Korach A, Rein AJ. N-terminal pro-Btype natriuretic peptite: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr 2004; 93:603-07.

109. Angelantonio ED, Castro SD, Toni D, Sacchetti ML, Biraschi F, Prencipe M, Fiorelli M. Determinants of plasma levels of brain natriuretic peptite after acute ischemic stroke or TIA Journal of the Neurological Sciences.2007;260:139–42.

110. Akademik Acil Tıp Dergisi 2010, Cilt:9 Sayı:1

111. Takahashi K, Totsune K, Sone M, et al. Human brain natriuretic peptite-like immunoreactivity in human brain. Peptites 1992; 13: 121-23.

112. Berendes E, Walter M, Cullen P, et al. Secretion of brain natriuretic peptite in patients with aneurysmal subarachnoid haemorrhage. Lancet 1997; 349: 245-49.

113. Fukui S, Katoh H, Tsuzuki N, Ishihara S, Otani N, Ooigawa H, Toyooka T, Ohnuki A, Miyazawa T, Nawashiro H, Shima K (2004) Focal brain edema and natriuretic peptites in patients with subarachnoid hemorrhage. J Clin Neurosci 11: 507–11.

114. Cole CD, Gottfried ON, Liu JK, et al. Hyponatremia in the neurosurgical patient: Diagnosis and management. Neurosurg Focus 2004; 16: 1-10.

115. Senio Y, Ogawa A, Yamashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker fort he detection and evaluation of heart failure. Eur J Heart Fail 2004; 6: 295-300.

116. Bay M, Kirk V, Parner J,Hassager C et al. NT-proBNP: A new diagnortic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 2003; 89: 150-154.

117. Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L et al. NT-Pro-Btype natriuretic peptite in infants and children: Reference values based on combined data from four studies. Pediatr Cardiol 2009; 30:3-8.

8. EKLER